DNLI
Denali Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$22.28
−2.28%0
Insider buys (3m)
2
Insider sells (3m)
-$136.5K
Net value (3m)
+14.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | Schuth Alexander O. · officer: COFO and Secretary | Sale | 2,768 | $23 |
| Aug 13, 2026 | Schuth Alexander O. · officer: COFO and Secretary | Sale | 2,857 | $25 |
| Jun 5, 2026 | Klein Peter S · director | A-Award | 19,226 | $20 |
| Jun 5, 2026 | Krognes Steve E. · director | A-Award | 19,226 | $20 |
| Jun 5, 2026 | Thornberry Nancy · director | A-Award | 19,226 | $20 |
| Jun 5, 2026 | Cook Jennifer E. · director | A-Award | 6,408 | $0.00 |
| Jun 5, 2026 | FLATLEY JAY T · director | A-Award | 19,226 | $20 |
| Jun 5, 2026 | Van Hauwermeiren Timothy · director | A-Award | 6,408 | $0.00 |
| Jun 5, 2026 | Cook Jennifer E. · director | A-Award | 19,226 | $20 |
| Jun 5, 2026 | Schenkein David P · director | A-Award | 6,408 | $0.00 |
| Jun 5, 2026 | BAKER BROS. ADVISORS LP · director | A-Award | 6,408 | $0.00 |
| Jun 5, 2026 | Van Hauwermeiren Timothy · director | A-Award | 19,226 | $20 |
| Jun 5, 2026 | BAKER BROS. ADVISORS LP · director | A-Award | 19,226 | $20 |
| Jun 5, 2026 | Klein Peter S · director | A-Award | 6,408 | $0.00 |
| Jun 5, 2026 | Thornberry Nancy · director | A-Award | 6,408 | $0.00 |
| Jun 5, 2026 | Krognes Steve E. · director | A-Award | 6,408 | $0.00 |
| Jun 5, 2026 | Schenkein David P · director | A-Award | 19,226 | $20 |
| Jun 5, 2026 | FLATLEY JAY T · director | A-Award | 6,408 | $0.00 |
| Jan 8, 2026 | Watts Ryan J. · director, officer: President and CEO | Sale | 35,198 | $17 |
| Jan 8, 2026 | Schuth Alexander O. · officer: COFO and Secretary | Sale | 17,218 | $17 |
| Jan 5, 2026 | Watts Ryan J. · director, officer: President and CEO | A-Award | 236,880 | $16 |
| Jan 5, 2026 | Schuth Alexander O. · officer: COFO and Secretary | A-Award | 57,700 | $0.00 |
| Jan 5, 2026 | Watts Ryan J. · director, officer: President and CEO | A-Award | 78,960 | $0.00 |
| Jan 5, 2026 | Schuth Alexander O. · officer: COFO and Secretary | A-Award | 173,100 | $16 |
| Dec 15, 2025 | BAKER BROS. ADVISORS LP · director | Purchase | 2,095,191 | $0.01 |
| Dec 15, 2025 | BAKER BROS. ADVISORS LP · director | Purchase | 190,523 | $0.01 |
| Nov 6, 2025 | Van Hauwermeiren Timothy · director | A-Award | 10,632 | $0.00 |
| Nov 6, 2025 | Van Hauwermeiren Timothy · director | A-Award | 31,897 | $15 |
| Aug 14, 2025 | Ho Carole · officer: Chief Medical Officer | Sale | 2,937 | $14 |
| Aug 14, 2025 | Schuth Alexander O. · officer: COFO and Secretary | Sale | 2,937 | $14 |
Institutional positioning
13F filings over the trailing two quarters
New 112Increased 229Reduced 127Sold out 29
| Filer | Action | Shares | Filed |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | Increased | 16,178,963 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 14,026,413 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 13,034,434 | May 13, 2026 |
| BAILLIE GIFFORD & CO | Reduced | 12,066,479 | May 8, 2026 |
| BAILLIE GIFFORD & CO | Reduced | 11,960,230 | Aug 6, 2026 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Increased | 8,519,192 | May 15, 2026 |
| STATE STREET CORP | Increased | 7,049,304 | Aug 7, 2026 |
| Temasek Holdings (Private) Ltd | Unchanged | 7,012,974 | Aug 7, 2026 |
| TEMASEK HOLDINGS (PRIVATE) LTD | Unchanged | 7,012,974 | May 12, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 6,477,057 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 6,275,729 | Aug 13, 2026 |
| STATE STREET CORP | Increased | 6,272,001 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 6,147,957 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 6,120,160 | May 8, 2026 |
| FMR LLC | Reduced | 4,575,374 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 3, 2026